Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone might help protect against severe lung problems in COVID-19 patients.

A substance from Caulerpa racemosa seaweed may protect against skin damage caused by air pollution by reducing oxidative stress and cell death.

Rosary Pea has medicinal benefits but requires careful handling due to its toxicity.

RALF22 is essential for root hair growth in response to fungal emissions in Arabidopsis.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Medieval people in Mallorca used ferns as medicine.

Abrus precatorius has medicinal benefits but can be toxic.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Annurca apple extract may help with hair growth and prevent hair loss.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Heptaminol may cause hair lightening in hemodialysis patients.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Promising cancer treatments were found, but the manufacturer closed.